Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
46 pending office actions • 30 art units • 45 examiners • 0 of 46 (0%) have an AI response strategy ready • 48 patents granted in the last 365 days
Osaka University maintains a large prosecution profile with 45 pending office actions in the Biotechnology & Pharmaceuticals technology area. This workload is distributed among 44 distinct examiners and 29 distinct art units. Such a wide distribution reflects the diverse nature of the university's biological and pharmaceutical research. The high number of technical departments involved indicates that the university's innovations are being classified across a broad spectrum of biotechnology fields.
Jennifer M.H. Tichy is the busiest examiner for the portfolio, managing 2 pending office actions. Because 44 examiners are handling 45 actions, nearly every application is being reviewed by a different person. This requires a highly decentralized strategy to manage the unique preferences of the many individuals involved. With only 2 actions assigned to the busiest examiner, no single person has a dominant influence. Practitioners must be prepared for a wide variety of departmental standards across the 29 art units.
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (7%) |
| §101 + other | 5 (11%) |
| §103 only | 8 (17%) |
| §102 only | 4 (9%) |
| §112 only | 3 (7%) |
| Double-patenting + other | 3 (7%) |
| Multi-statute (no §101) | 20 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TICHY, JENNIFER M.H. | 2 | 64.9% | +34.5% |
| LAVARIAS, ARNEL C | 1 | 79.8% | +0.3% |
| MEDICH, ANGELA MARGOT | 1 | 66.9% | +19.7% |
| MOLOYE, TITILAYO | 1 | 62.5% | +47.9% |
| HOFFPAUIR, ANDREW ELI | 1 | 41.4% | +52.1% |
| PECKHAM, RICHARD GRANT | 1 | 68.1% | +35.1% |
| RUIZ, JOSHUA DAMIAN | 1 | 0.0% | +0.0% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| SHIAO, YIH-HORNG | 1 | 72.5% | +75.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042430 | GRAPHENE GRID, METHOD FOR PRODUCING GRAPHENE GRID, AND METHOD FOR ANALYZING STRUCTURAL ANALYSIS TARGET SUBSTANCE | STOFFA, WYATT A | 44d overdue |
| 17639483 | PARACENTESIS ASSISTANCE SYSTEM, PARACENTESIS ASSISTANCE METHOD, AND PROGRAM | GUERRERO ROSARIO, ANA VERUSKA | 6d |
| 18032169 | JOINT EVALUATION APPARATUS, METHOD, AND STORAGE MEDIUM | ROBERTS, ANNA L | 14d |
| 17775780 | ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDE | SINGH, ANOOP KUMAR | 27d |
| 18844708 | TREATMENT-METHOD SELECTION ASSISTANCE APPARATUS, TREATMENT-METHOD SELECTION ASSISTANCE METHOD, AND COMPUTER-READABLE MEDIUM | RUIZ, JOSHUA DAMIAN | 33d |
| 18662314 | POROUS PARTICLES | SINGH-PANDEY, ARTI R | 33d |
| 18710932 | IRRADIATION DEVICE AND IRRADIATION METHOD | CONLON, MARISA V | 62d |
| 18873153 | OPTICAL ELEMENT | LAVARIAS, ARNEL C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17386776 | DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME | TICHY, JENNIFER M.H. | 5d overdue |
| 18947096 | LIQUID CRYSTAL OPTICAL ELEMENT | MEDICH, ANGELA MARGOT | — |
| 18863725 | METHOD FOR COLLECTING STEM CELLS FROM ANIMAL TISSUE | MOLOYE, TITILAYO | — |
| 18705271 | COGNITIVE FUNCTION EVALUATION SYSTEM AND LEARNING METHOD | HOFFPAUIR, ANDREW ELI | — |
| 18850038 | MICROWAVE ABSORBER | PECKHAM, RICHARD GRANT | — |
| 18784235 | Organoid Compositions | SCHUBERG, LAURA J | — |
| 18733430 | METHOD FOR SEPARATING COMPONENTS USING SUPERCRITICAL FLUID CHROMATOGRAPH | SHIAO, YIH-HORNG | — |
| 18282450 | PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN | TICHY, JENNIFER M.H. | — |
| Art Unit | Apps |
|---|---|
| 1759 | 3 |
| 1632 | 2 |
| 1653 | 2 |
| 3791 | 2 |
| 1658 | 2 |
| 2872 | 1 |
| 1743 | 1 |
| 3684 | 1 |
| 3643 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18873153 | OPTICAL ELEMENT | LAVARIAS, ARNEL C | 2872 | §102§103 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18947096 | LIQUID CRYSTAL OPTICAL ELEMENT | MEDICH, ANGELA MARGOT | — | §102§103§112 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18863725 | METHOD FOR COLLECTING STEM CELLS FROM ANIMAL TISSUE | MOLOYE, TITILAYO | 1632 | §102§103§112 | Non-Final OA | — | Pending | Nov 07, 2024 |
| 18705271 | COGNITIVE FUNCTION EVALUATION SYSTEM AND LEARNING METHOD | HOFFPAUIR, ANDREW ELI | — | §101§103§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18850038 | MICROWAVE ABSORBER | PECKHAM, RICHARD GRANT | 1743 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18844708 | TREATMENT-METHOD SELECTION ASSISTANCE APPARATUS, TREATMENT-METHOD SELECTION ASSISTANCE METHOD, AND COMPUTER-READABLE MEDIUM | RUIZ, JOSHUA DAMIAN | 3684 | §101§103§112 | Final Rejection | 33d | Pending | Sep 06, 2024 |
| 18835370 | PHENOXAZINE DERIVATIVE AND DRUG DELIVERY SYSTEM FORMULATION USING SAME | BERRY, LAYLA D | — | §102§112 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18784235 | Organoid Compositions | SCHUBERG, LAURA J | — | §102DP | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18733430 | METHOD FOR SEPARATING COMPONENTS USING SUPERCRITICAL FLUID CHROMATOGRAPH | SHIAO, YIH-HORNG | — | §102§103§112 | Non-Final OA | — | Pending | Jun 04, 2024 |
| 18710932 | IRRADIATION DEVICE AND IRRADIATION METHOD | CONLON, MARISA V | 3643 | §103§112 | Final Rejection | 62d | Pending | May 16, 2024 |
| 18662314 | POROUS PARTICLES | SINGH-PANDEY, ARTI R | 1759 | §102§112 | Non-Final OA | 33d | Pending | May 13, 2024 |
| 18705643 | 3D PRINTING SUPPORT MATERIAL AND METHOD FOR MANUFACTURING SAME | CHO, DAVID H | 1693 | §102§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18648087 | PRODUCTION METHOD OF MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF | BATES, KEENAN ALEXANDER | — | §112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18687110 | LAMINATED BODY HAVING RESIN LAYER AND METAL LAYER AND PRODUCTION METHOD FOR SAME | JACKSON, MONIQUE R | 1787 | §103 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18293488 | RADIOLABELED COMPOUND AND USE THEREOF | LEWOCZKO, EVAN MICHAEL | — | §103§112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18577263 | Mature-Hepatocyte Transdifferentiation Suppressing Composition | CLARK, AMY LYNN | 1628 | §103§112 | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18418347 | QUANTUM COMPUTATION METHOD AND INFORMATION PROCESSING APPARATUS | NGUYEN, MAIKHANH | — | §102 | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18579988 | Method for Creating Isotope Distribution Data | SIMMONS, VALERIE MICHELLE | — | §101§102§103 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18392869 | CHIMERIC DOUBLE-STRANDED NUCLEIC ACID | ZARA, JANE J | — | §112DP | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18288867 | MEASUREMENT DEVICE | MALAMUD, DEBORAH LESLIE | 3792 | §102§103 | Final Rejection | — | Pending | Oct 30, 2023 |
| 18282450 | PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN | TICHY, JENNIFER M.H. | 1653 | §102§103 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18279557 | CELL FUSION METHOD | BELYAVSKYI, MICHAIL A | 1644 | §102 | Non-Final OA | — | Pending | Aug 30, 2023 |
| 18278931 | TEST FOR MILD COGNITIVE IMPAIRMENT | MCCOLLUM, ANDREA K | 1674 | §102 | Final Rejection | — | Pending | Aug 25, 2023 |
| 18275245 | SPECTROMETRY DEVICE AND SPECTROMETRY METHOD | SCHNASE, PAUL DANIEL | 2877 | §103 | Final Rejection | 5d | Pending | Aug 01, 2023 |
| 18273767 | EXERCISE SUPPORT APPARATUS, EXERCISE SUPPORT METHOD, EXERCISE SUPPORT SYSTEM, AND STORAGE MEDIUM | RENWICK, REGINALD A | 3715 | §101 | Non-Final OA | — | Pending | Jul 22, 2023 |
| 18142863 | COPOLYMER | BLAND, ALICIA | 1759 | §102 | Non-Final OA | — | Pending | May 03, 2023 |
| 18032169 | JOINT EVALUATION APPARATUS, METHOD, AND STORAGE MEDIUM | ROBERTS, ANNA L | 3791 | §101 | Final Rejection | 14d | Pending | Apr 15, 2023 |
| 18126045 | TEMPERATURE ESTIMATION DEVICE, AIR CONDITIONING CONTROL DEVICE, AND AIR CONDITIONING SYSTEM | CHANG, VINCENT WEN-LIANG | 2119 | §103 | Non-Final OA | 59d overdue | Pending | Mar 24, 2023 |
| 18027695 | Wnt SIGNALING PATHWAY INHIBITOR | FISCHER, JOSEPH | 1658 | §102§112Other | Non-Final OA | — | Pending | Mar 22, 2023 |
| 18023573 | IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN | WEIDNER, ADAM M | 1600 | §101§103§112 | Non-Final OA | — | Pending | Feb 27, 2023 |
| 18042430 | GRAPHENE GRID, METHOD FOR PRODUCING GRAPHENE GRID, AND METHOD FOR ANALYZING STRUCTURAL ANALYSIS TARGET SUBSTANCE | STOFFA, WYATT A | 2881 | §103§112 | Non-Final OA | 44d overdue | Pending | Feb 21, 2023 |
| 18157250 | METHOD OF ASSISTING DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE | COUNTS, GARY W | 1678 | §112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18008652 | MULTI-COMPONENT SYSTEM ALLOY | ROE, JESSEE RANDALL | 1759 | §103 | Final Rejection | 14d | Pending | Dec 06, 2022 |
| 17999347 | EPITHELIAL CANCER THERAPEUTIC AGENT | WORSHAM, JESSICA N | 1615 | §102§103 | Non-Final OA | — | Pending | Nov 18, 2022 |
| 17926348 | BRANCHED CONNECTOR AND CATHETER | LEGETTE-THOMPSON, TIFFANY | 1723 | §102§103§112 | Final Rejection | — | Pending | Nov 18, 2022 |
| 17925099 | GOLD NANOPARTICLE-CONTAINING MEDICINE | GREENE, IVAN A | 1619 | §102§103§112 | Non-Final OA | — | Pending | Nov 14, 2022 |
| 17925123 | TUBE ASSEMBLY FOR LIVING ORGANISM AND MEASUREMENT APPARATUS FOR LIVING ORGANISM | CHOU, WILLIAM B | 3795 | §103 | Final Rejection | 15d | Pending | Nov 14, 2022 |
| 17913066 | COGNITIVE IMPAIRMENT DIAGNOSTIC DEVICE AND COGNITIVE IMPAIRMENT DIAGNOSTIC PROGRAM | PARK, EVELYN GRACE | 3791 | §103 | Final Rejection | — | Pending | Sep 20, 2022 |
| 17802045 | RESIN MATERIAL INCLUDING SILOXANE-BOND-CONTAINING POLYMER HAVING HOST GROUP AND/OR GUEST GROUP | BERRO, ADAM JOSEPH | 1765 | §102§103 | Final Rejection | — | Pending | Aug 24, 2022 |
| 17801115 | DIGESTIVE FLUID LEAK PREVENTATIVE MATERIAL AND ORGAN PROTECTIVE MATERIAL AGAINST DIGESTION BY DIGESTIVE FLUID | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | 19d | Pending | Aug 19, 2022 |
| 17775780 | ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDE | SINGH, ANOOP KUMAR | 1632 | §102§103§112 | Final Rejection | 27d | Pending | May 10, 2022 |
| 17639483 | PARACENTESIS ASSISTANCE SYSTEM, PARACENTESIS ASSISTANCE METHOD, AND PROGRAM | GUERRERO ROSARIO, ANA VERUSKA | 3794 | §103§112 | Non-Final OA | 6d | Pending | Mar 01, 2022 |
| 17386776 | DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | 5d overdue | Pending | Jul 28, 2021 |
| 17264496 | Super Versatile Method for Imparting New Binding Specificity to Antibody | AUDET, MAURY A | 1654 | §103§112 | Non-Final OA | — | Pending | Jan 29, 2021 |
| 16971604 | ANALYSIS/DIAGNOSIS METHOD UTILIZING RNA MODIFICATION | ANGELL, JON E | 1637 | §101 | Final Rejection | — | Pending | Nov 10, 2020 |
| 17085040 | Pharmaceutical Composition for Cancer Treatment | STOICA, ELLY GERALD | 1647 | §112 | Final Rejection | 9d overdue | Pending | Oct 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial